Endocrine Evaluation and Management of the Perioperative Cancer Patient

Acute Care of the Cancer Patient

Volumn , Issue , 2005, Pages 43-67

  Waguespack, Steven ^a   Gagel, Robert F ^a   Maldonado, Mario ^b   Sekhar, Rajagopal V ^b   Balasubramaian, Shok ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85134971918     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (81)

1. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414:782-787.
2. Pandit MK, Burke J, Gustafson AB, Minocha A, Peiris AN. Drug-induced disorders of glucose tolerance. Ann Intern Med 1993; 118:529-539.
3. Rosenberg CS. Wound healing in the patient with diabetes mellitus. Nurs Clin North Am 1990; 25:247-261.
4. McMahon MM, Bistrian BR. Host defenses and susceptibility to infection in patients with diabetes mellitus. Infect Dis Clin North Am 1995; 9:1-9.
5. Tomas E, Lin YS, Dagher Z, Saha A, Luo Z, Ido Y, Ruderman NB. Hyperglycemia and insulin resistance: possible mechanisms. Ann N Y Acad Sci 2002; 967:43-51.
6. Tayek J. A review of cancer cachexia and abnormal glucose metabolism in humans with cancer. J Am Coll Nutr 1992; 11:445-456.
7. Poulson J. The management of diabetes in patients with advanced cancer. J Pain Symptom Manage 1997; 13:339-346.
8. Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. Br Med J 1997; 314:1512-1515.
9. Malmberg K, Norhammar A, Ryden L. Insulin treatment post myocardial infarction: The DIGAMI study. Adv Exp Med Biol 2001; 498:279-284.
10. Diaz R, Paolasso EA, Piegas LS, Tajer CD, Moreno MG, Corvalan R, Isea JE, Romero G. Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiologicos Latinoamerica) Collaborative Group. Circulation 1998; 98:2227-2234.
11. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the surgical intensive care unit. N Engl J Med 2001; 345:1359-1367.
12. Levetan CS, Magee MF. Hospital management of diabetes. Endocrinol Metab Clin North Am 2000; 29:745-770.
13. Kanaya AM, Harris F, Volpato S, Perez-Stable EJ, Harris T, Bauer DC. Association between thyroid dysfunction and total cholesterol level in an older biracial population: The health, aging and body composition study. Arch Intern Med 2002; 162:773-779.
14. Mya MM, Aronow WS. Subclinical hypothyroidism is associated with coronary artery disease in older persons. J Gerontol A Biol Sci Med Sci 2002; 57: M658-M659.
15. Murkin JM. Anesthesia and hypothyroidism: A review of thyroxine physiology, pharmacology, and anesthetic implications. Anesth Analg 1982; 61:371-383.
16. Duntas LH. Thyroid disease and lipids. Thyroid 2002; 12:287-293.
17. Villabona C, Sahun M, Roca M, Mora J, Gomez N, Gomez JM, Puchal R, Soler J. Blood volumes and renal function in overt and subclinical primary hypothyroidism. Am J Med Sci 1999; 318:277-280.
18. Sarich TC, Wright JM. Hypothyroxinemia and phenytoin toxicity: A vicious circle. Drug Metabol Drug Interact 1996; 13:155-160.
19. O’Connor P, Feely J. Clinical pharmacokinetics and endocrine disorders. Therapeutic implications. Clin Pharmacokinet 1987; 13:345-364.
20. Muller B, Tsakiris DA, Roth CB, Guglielmetti M, Staub JJ, Marbet GA. Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease. Eur J Clin Invest 2001; 31: 131-137.
21. Ladenson PW, Goldenheim PD, Ridgway EC. Prediction and reversal of blunted ventilatory responsiveness in patients with hypothyroidism. Am J Med 1988; 84: 877-883.
22. Hiasa Y, Ishida T, Aihara T, Bando M, Nakai Y, Kataoka Y, Mori H. Acute myocardial infarction due to coronary spasm associated with l-thyroxine therapy. Clin Cardiol 1989; 12:161-163.
23. Arlot S, Debussche X, Lalau JD, Mesmacque A, Tolani M, Quichaud J, Fournier A. Myxoedema coma: Response of thyroid hormones with oral and intravenous high-dose l-thyroxine treatment. Intensive Care Med 1991; 17:16-18.
24. Wolfson B, Smith K. Cardiac arrest following minor surgery in unrecognized thyrotoxicosis: A case report. Anesth Analg 1968; 47:672-676.
25. Pugh S, Lalwani K, Awal A. Thyroid storm as a cause of loss of consciousness following anaesthesia for emergency caesarean section. Anaesthesia 1994; 49:35-37.
26. Bennett MH, Wainwright AP. Acute thyroid crisis on induction of anaesthesia. Anaesthesia 1989; 44:28-30.
27. Robson NJ. Emergency surgery complicated by thyrotoxicosis and thyrotoxic periodic paralysis. Anaesthesia 1985; 40:27-31.
28. Ragaller M, Quintel M, Bender HJ, Albrecht DM. [Myxedema coma as a rare postoperative complication]. Anaesthesist 1993; 42:179-183.
29. Sherry KM, Hutchinson IL. Postoperative myxoedema. A report of coma and upper airway obstruction. Anaesthesia 1984; 39:1112-1114.
30. Mizuno J, Nakayama Y, Dohi T, Tokioka H. A case of hypothyroidism found by delayed awakening after the operation. Masui 2000; 49:305-308.
31. Tsubokawa T, Yamamoto K, Kobayashi T. Propofol clearance and distribution volume increase in patients with hyperthyroidism. Anesth Analg 1998; 87:195-199.
32. Matsumoto S, Unoshima M, Takeshima N, Yamamoto H, Yoshitake S, Noguchi T. Hemodynamic effects of propofol as an anesthesia induction agent in hyperthyroidism patients on chronic beta-blocker. Masui 2000; 49:976-980.
33. Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid strom. Endocrinol Metab Clin North Am 1993; 22:263-277.
34. Nishio W, Takahata O, Yamamoto Y, Mamiya K, Iwasaki H. Perioperative management using propofol in a patient with uncontrolled preoperative hyperthyroidism. Masui 2001; 50:655-657.
35. Yoshida D. Thyroid storm precipitated by trauma. J Emerg Med 1996; 14:697-701.
36. Burger AG, Philippe J. Thyroid emergencies. Baillieres Clin Endocrinol Metab 1992; 6:77-93.
37. Nishiyama K, Kitahara A, Natsume H, Matsushita A, Nakano K, Sasaki S, Genma R, Yamamoto Y, Nakamura H. Malignant hyperthermia in a patient with Graves’ disease during subtotal thyroidectomy. Endocr J 2001; 48:227-232.
38. So PC. Unmasking of thyrotoxicosis during anaesthesia. Hong Kong Med J 2001; 7:311-314.
39. Palit TK, Miller CC III, Miltenburg DM. The efficacy of thyroidectomy for Graves’ disease: A meta-analysis. J Surg Res 2000; 90:161-165.
40. Ladenson PW, Levin AA, Ridgway EC, Daniels GH. Complications of surgery in hypothyroid patients. Am J Med 1984; 77:261-266.
41. Weinberg AD, Brennan MD, Gorman CA, Marsh HM, O’Fallon WM. Outcome of anesthesia and surgery in hypothyroid patients. Arch Intern Med 1983; 143:893-897.
42. Sherman SI, Ladenson PW. Percutaneous transluminal coronary angioplasty in hypothyroidism. Am J Med 1991; 90:367-370.
43. Mantzoros CS, Evagelopoulou K, Moses AC. Outcome of percutaneous transluminal coronary angioplasty in patients with subclinical hypothyroidism. Thyroid 1995; 5:383-387.
44. Lenders JW, Keiser HR, Goldstein DS, Willemsen JJ, Friberg P, Jacobs MC, Kloppenborg PW, Thien T, Eisenhofer G. Plasma metanephrines in the diagnosis of pheochromocytoma. Ann Intern Med 1995; 123: 101-109.
45. Laursen K, Damgaard-Pedersen K. CT for pheochromocytoma diagnosis. Am J Roentgenol 1979; 134: 277-280.
46. Fujita A, Hyodoh H, Kawamura Y, Kanegae K, Furuse M, Kanazawa K. Use of fusion images of I-131 metaiodobenzylguanidine, SPECT, and magnetic resonance studies to identify a malignant pheochromocytoma. Clin Nucl Med 2000; 25:440-442.
47. Kelly DF, Gonzalo IT, Cohan P, Berman N, Swerdloff R, Wang C. Hypopituitarism following traumatic brain injury and aneurysmal subarachnoid hemorrhage: A preliminary report. J Neurosurg 2000; 93: 743-752.
48. McGlynn T, Simons R. Endocrine disorders. Kammerer W, Gross RMedical Consultation; The Internist on Surgical, Obstetric, and Psychiatric Services. 2nd ed. Philadelphia: Lippincott, Williams & Wilkins, 1990: 275-309.
49. Udelsman R, Norton JA, Jelenich SE, Goldstein DS, Linehan WM, Loriaux DL, Chrousos GP. Responses of the hypothalamic-pituitary-adrenal and renin-angiotensin axes and the sympathetic system during controlled surgical and anesthetic stress. J Clin Endocrinol Metab 1987; 64:986-994.
50. Lamberts SW, Bruining HA, de Jong FH. Corticosteroid therapy in severe illness. N Engl J Med 1997; 337:1285-1292.
51. Welsh GA, Manzullo E, Orth DN. The surgical patient taking corticosteroids. In: Rose BD, ed. UpToDate. Online 11.2 ed. Wellesley, MA: UpToDate, 2003.
52. Salem M, Tainsh RE, Jr, Bromberg J, Loriaux DL, Chernow B. Perioperative glucocorticoid coverage. A reassessment 42 years after emergence of a problem. Ann Surg 1994; 219:416-425.
53. Hadley JS, Hinds CJ. Anabolic strategies in critical illness. Curr Opin Pharmacol 2002; 2:700-707.
54. Takala J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, Vundelinckx G, Hinds CJ. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999; 341:785-792.
55. Singer PA, Sevilla LJ. Postoperative endocrine management of pituitary tumors. Neurosurg Clin N Am 2003; 14:123-138.
56. Vance ML. Perioperative management of patients undergoing pituitary surgery. Endocrinol Metab Clin North Am 2003; 32:355-365.
57. Olson BR, Gumowski J, Rubino D, Oldfield EH. Pathophysiology of hyponatremia after transsphenoidal pituitary surgery. J Neurosurg 1997; 87:499-507.
58. Rolih CA, Ober KP. Pituitary apoplexy. Endocrinol Metab Clin North Am 1993; 22:291-302.
59. da Motta LA, de Mello PA, de Lacerda CM, Neto AP, da Motta LD, Filho MF. Pituitary apoplexy. Clinical course, endocrine evaluations and treatment analysis. J Neurosurg Sci 1999; 43:25-36.
60. Fuchs S, Beeri R, Hasin Y, Weiss AT, Gotsman MS, Zahger D. Pituitary apoplexy as a first manifestation of pituitary adenomas following intensive thrombolytic and antithrombotic therapy. Am J Cardiol 1998; 81:110-111.
61. Otsuka F, Kageyama J, Ogura T, Makino H. Pituitary apoplexy induced by a combined anterior pituitary test: Case report and literature review. Endocr J 1998; 45:393-398.
62. Watanabe K, Adachi A, Nakamura R. Reversible panhypopituitarism due to Cushing’s syndrome. Arch Intern Med 1988; 148:1358-1360.
63. Chen JC, Amar AP, Choi S, Singer P, Couldwell WT, Weiss MH. Transsphenoidal microsurgical treatment of Cushing disease: Postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test. J Neurosurg 2003; 98: 967-973.
64. Bochicchio D, Losa M, Buchfelder M, Institute of Endocrine Sciences OMIMI. Factors influencing the immediate and late outcome of Cushing’s disease treated by transsphenoidal surgery: A retrospective study by the European Cushing’s Disease Survey Group. J Clin Endocrinol Metab 1995; 80(11):3114-3120.
65. Jackson JA, Trowbridge A, Smigiel M. Fatal pulmonary thromboembolism after successful transsphenoidal hypophysectomy for Cushing’s disease. South Med J 1990; 83:960-962.
66. Ben-Shlomo A, Melmed S. Clinical review 154: The role of pharmacotherapy in perioperative management of patients with acromegaly. J Clin Endocrinol Metab 2003; 88:963-968.
67. Seidman PA, Kofke WA, Policare R, Young M. Anaesthetic complications of acromegaly. Br J Anaesth 2000; 84:179-182.
68. Glowniak JV, Loriaux DL. A double-blind study of perioperative steroid requirements in secondary adrenal insufficiency. Surgery 1997; 121:123-129.
69. Bromberg JS, Alfrey EJ, Barker CF, Chavin KD, Dafoe DC, Holland T, Naji A, Perloff LJ, Zellers LA, Grossman RA. Adrenal suppression and steroid supplementation in renal transplant recipients. Transplantation 1991; 51:385-390.
70. Schlaghecke R, Kornely E, Santen RT, Ridderskamp P. The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone. N Engl J Med 1992; 326: 226-230.
71. Esteban NV, Loughlin T, Yergey AL, Zawadzki JK, Booth JD, Winterer JC, Loriaux DL. Daily cortisol production rate in man determined by stable isotope dilution=mass spectrometry. J Clin Endocrinol Metab 1991; 72:39-45.
72. Kerrigan JR, Veldhuis JD, Leyo SA, Iranmanesh A, Rogol AD. Estimation of daily cortisol production and clearance rates in normal pubertalmales by deconvolution analysis. J Clin Endocrinol Metab 1993; 76:1505-1510.
73. Yeung SJ, Lazo-Diaz G, Gagel RF. Metabolic and endocrine emergencies. In: Yeung SJ, Escalante CP eds. Oncologic Emergencies. 1st ed. Hamilton, Ontario: BC Decker Inc, 2002:103-144.
74. Kamoi K, Ebe T, Kobayashi O, Ishida M, Sato F, Arai O, Tamura T, Takagi A, Yamada A, Ishibashi M, et al. Atrial natriuretic peptide in patients with the syndrome of inappropriate antidiuretic hormone secretion and with diabetes insipidus. J Clin Endocrinol Metab 1990; 70:1385-1390.
75. Miller M. Syndromes of excess antidiuretic hormone release. Crit Care Clin 2001; 17:11-23.
76. Adrogue HJ, Madias NE. Hyponatremia. N Engl J Med 2000; 342:1581-1589.
77. Lampl C, Yazdi K. Central pontine myelinolysis. Eur Neurol 2002; 47:3-10.
78. Sterns RH. The management of symptomatic hyponatremia. Semin Nephrol 1990; 10:503-514.
79. Harrigan MR. Cerebral salt wasting syndrome. Crit Care Clin 2001; 17:125-138.
80. Betjes MG. Hyponatremia in acute brain disease: The cerebral salt wasting syndrome. Eur J Int Med 2002; 13:9-14.
81. Singer I, Oster JR, Fishman LM. The management of diabetes insipidus in adults. Arch Intern Med 1997; 157:1293-1301.